Developing vaccines that enhance the immune response against bacterial infections
Delivery of anti-bacterial glycan vaccines to cells and subcellular compartments
This study is testing new vaccines made from tiny particles that look like viruses to help your immune system better fight off bacterial infections, with the hope that these vaccines will provide stronger protection against diseases caused by bacteria.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11082438 on NIH RePORTER |
What this research studies
This research focuses on creating innovative vaccines using virus-like particles (VLPs) that can effectively stimulate the immune system to fight bacterial infections. By modifying these particles to display specific molecules, the project aims to improve how the immune system recognizes and responds to bacteria. The approach involves delivering these vaccines over extended periods to enhance the immune response through continuous exposure to the antigens. Patients may benefit from a more effective vaccine that could lead to better protection against bacterial diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of bacterial infections or those who have experienced recurrent bacterial diseases.
Not a fit: Patients with viral infections or those who do not have a history of bacterial infections may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that significantly improve the immune response against bacterial infections.
How similar studies have performed: Previous research has shown promise in using virus-like particles for vaccine development, indicating a potential for success with this novel approach.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Finn, M.g. — Scripps Research Institute, the
- Study coordinator: Finn, M.g.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.